APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling

Petty, R D, Samuel, L M, Murray, G I, MacDonald, G, O'Kelly, T, Loudon, M, Binnie, N, Aly, E, McKinlay, A, Wang, W, Gilbert, F, Semple, S & Collie-Duguid, E S R 2009, 'APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling', BMC Cancer, vol. 9, 434, pp. 434. https://doi.org/10.1186/1471-2407-9-434